Skip to content

Dexmedetomidine Versus Ketamine Loading for Dexmedetomidine Sedation During Elective Cesarean Section Under Spinal Anesthesia

Dexmedetomidine Versus Ketamine Loading for Dexmedetomidine Sedation During Elective Cesarean Section Under Spinal Anesthesia: A Prospective Randomized Double-Blind Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07676955
Acronym
Sedation
Enrollment
80
Registered
2026-06-30
Start date
2021-06-01
Completion date
2021-12-31
Last updated
2026-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Birth, Sedation, Spinal Anesthesia

Keywords

Cesarean section, spinal anesthesia, Dexmedetomidine, Ketamine, Sedation, Apgar score

Brief summary

This is a prospective, randomized, double-blind clinical study designed to compare the maternal and early neonatal effects of a loading dose of dexmedetomidine versus low-dose ketamine in parturients undergoing elective cesarean delivery under spinal anesthesia. Participants will be randomly assigned to receive either an intravenous loading dose of dexmedetomidine (1 μg/kg) or intravenous ketamine (0.15 mg/kg) immediately after the establishment of spinal anesthesia. In both groups, sedation will be maintained with a continuous dexmedetomidine infusion at a rate of 0.5 μg/kg/h. The primary and secondary outcomes include maternal hemodynamic parameters, sedation levels, patient and surgeon satisfaction scores, neonatal Apgar scores, and perioperative adverse events.

Detailed description

This prospective, randomized, double-blind clinical study is designed to evaluate and compare the maternal and early neonatal effects of a loading dose of dexmedetomidine versus low-dose ketamine in parturients undergoing elective cesarean delivery under spinal anesthesia. After providing written informed consent, eligible parturients will be randomly assigned to one of two study groups. Randomization will be performed using a computer-generated randomization sequence. Blinding will be maintained for both participants and outcome assessors. Following the establishment of spinal anesthesia, patients will receive either an intravenous loading dose of dexmedetomidine (1 μg/kg) or ketamine (0.15 mg/kg). In both groups, sedation will be maintained with a continuous infusion of dexmedetomidine at a rate of 0.5 μg/kg/h throughout the intraoperative period. Maternal hemodynamic parameters (including heart rate and blood pressure), sedation levels, patient and surgeon satisfaction scores, neonatal Apgar scores, and perioperative adverse events will be recorded at predefined time points throughout the perioperative period. Standard anesthetic and surgical care will be provided to all participants. The primary objective of the study is to compare the effects of dexmedetomidine and ketamine on maternal hemodynamic stability. Secondary outcomes include the quality of sedation, patient and surgeon satisfaction, neonatal outcomes, and perioperative adverse events.

Interventions

DRUGDexmedetomidine

Maintenance sedation was achieved with dexmedetomidine infusion at 0.5 μg/kg/h after dexmedetomidine loading.

DRUGKetamine

Patients received intravenous ketamine 0.15 mg/kg over 10 minutes

Sponsors

Haseki Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* American Society of Anesthesiologists (ASA) physical classification status I patients * aged \>18 years scheduled for cesarean/section surgery under spinal anesthesia were enrolled to the study

Exclusion criteria

* known sensitivity or allergy to study drugs * a history of analgesic or narcotic abuse * any contraindications for spinal anesthesia * emergency cesarean/section * existing of fetal distress.

Design outcomes

Primary

MeasureTime frameDescription
Ramsey sedation score1)immediately before spinal anesthesia (SA) 2)5 minutes after SA, 3)immediately after the loading dose was completed, 4)immediately before surgical incision, 5)5 minutes after surgical incision, 6)5 minutes after the surgical closure.Sedation score was evaluated by Ramses Sedation Score (RSS). RSS score was as follow: Awake; agitated or restless or both =1 Awake; cooperative, oriented, and tranquil=2 Awake but responds to commands only=3 Asleep; brisk response to light glabellar tap or loud auditory stimulus=4 Asleep; sluggish response to light glabellar tap or loud auditory stimulus=5 Asleep; no response to glabellar tap or loud auditory stimulus=6

Secondary

MeasureTime frameDescription
hemodynamic parametersIn the operating room; from immediately before the induction of anesthesia to transferring to ward with 5 minutes intervalsArterial blood pressure (mmHg), heart rate (beats per mimute)
patient and surgeon satisfaction scoresat day 1 postoperatively.Patient and Surgeon satisfaction were evaluated using four-point rating scale: 1=poor, 2=fair, 3=good, 4=excellent.
APGAR scoreThe Apgar score is assessed at 1 minute and 5 minutes after birth.The score evaluates five parameters, each graded from 0 to 2, for a maximum total of 10 points: Appearance (Skin color): Blue or pale= 0 point, Body pink, extremities blue=1 point, Completely pink=2 points Pulse (Heart rate): Absent=0 point, \<100 beats/min (minutes)=1 point, ≥100 beats/min=2 points Grimace (Reflex irritability): No response=0 point, Grimace Cries= 1 point, coughs, or pulls away=2 points Activity (Muscle tone): Limp=0 point, Some flexion=1 point, Active movement=2 points Respiration (Breathing effort): Absent=0 point, Slow or irregular=1 point, Good, strong crying=2 points

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORHalil C Canatan

Ozel Duygu Hastanesi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 1, 2026